3354 Prognostic factors for survival in patients with metastatic melanoma treated with ipilimumab: Turkish Oncology Group (TOG) Study. (September 2015) - Urun, Y.; Abal, H.; Turna, H.; Esin, E.; Sedef, A.M.; Alkan, A.; Oksüzoğlu, B.; Ozdemir, N.Y.; Sendur, M.A.N.; Sezer, A.; Kiliçkap, S.; Akbulut, H.; et al.